Background: With the completion of the human draft genome sequence, efforts are now devoted to identifying new genes. We have developed a computer-based strategy that utilizes the EST database to identify new genes that could be targets for the immunotherapy of cancer or could be involved in the multistep process of cancer. Materials and Methods: Utilizing our computer-based screening strategy, we identified a cluster of expressed sequence tags (ESTs) that are highly expressed in breast cancer. Northern blot and reverse transcriptase polymerase chain reaction (RT-PCR) analyses demonstrated the tissue specificity of the computer-generated cluster and comparison with the human genome sequence assisted in isolating a full-length cDNA clone. Results: We identified a new gene that is highly expressed in breast cancer. This gene is expressed at moderate levels in normal breast and testis and at very low levels in liver,
Introduction
Expressed sequence tags (EST) are sequences derived from randomly selected clones from various cDNA libraries. Because each cDNA clone is generated from a transcript, the frequency and distribution of the many different transcripts in any given tissue depend on the tissue-specific activity of the expressed genes. Therefore ESTs provide a valuable source of information about the expression patterns of certain genes in different types of tissues (1, 2) . With the completion of the human draft genome sequence, much effort is now devoted to identifying new genes for a variety of purposes. Our laboratory is interested in identifying new genes that could be targets for the immunotherapy of prostate cancer or could be involved in the multistep process of prostate cancer. To accomplish this we have developed a computer-based screening strategy that uses the EST database and generates clusters of ESTs that are expressed in normal prostate and/or prostate cancer but not in essential human tissues (3) (4) (5) (6) (7) . We have now utilized the same computer screening strategy to identify EST clusters that are specifically expressed in normal breast and/or breast cancer.
Breast cancer is the most common type of epithelial cancer among women in the United States. More than 180,000 women are diagnosed with breast cancer each year. About one in eight women in the United States (approximately 12.8%) will develop breast cancer during her lifetime. At present there are no curative therapies available for breast cancer that has metastasized from its site of origination and there is urgent need for developing new targets for breast cancer therapy.
In this study, using a cluster of ESTs as a lead to screen and search human cDNA libraries, we identified a new gene expressed in many breast cancer samples. The protein it encodes is a new member of ATP-binding cassette (ABC) transporter superfamily and is a member of ABCC subfamily (ABCC11). Our data show that a variant of this gene is highly expressed in breast cancer and could be a potential molecular target for the treatment of breast cancer.
Materials and Methods

EST Database Mining and Computer Analysis
The ESTs from human tissues and tumor libraries were downloaded from the National Center for Biotechnology Information dbEST database. As of February 2001, this database contains over 2.5 million human EST sequences from 4673 libraries, of which 119,163 ESTs are from human breast and breast cancer. The EST sequences were clustered and sorted as described previously (8) . The corresponding Unigene cluster for the individual candidate was identified and analyzed. Alignment information of the individual EST with the genomic sequence was obtained from "Golden Path" browser (http://genome.cse.ucsc.edu/goldenPath/hgTracks. html). The cDNA sequences determined experimentally were aligned with the genomic sequences using Blat, ClustalW, and Blast programs. GenomeScan and GrailEXP gene prediction programs were used to predict genes and the PHD procedure in the PredictProtein program package was used to identify putative transmembrane regions.
RNA Dot Blots and Northern Blot Hybridization
RNA hybridization was performed on multiple tissue northern blots (MTN, Clontech, Palo Alto, CA, USA) and a Human Multiple Tissue Expression Array (Clontech, Cat# 7775-1) containing mRNA from 76 human tissues in separate dots. The 400-bp polymerase chain reaction (PCR) fragment generated by primer T352 and T354 was used as a probe. The sequence of the primers used in this study is described in Table 1 . For a breast-specific probe, a 480-bp PCR fragment was generated using primer pair T377 and T389 based on the 5Ј DNA sequence of the 4.5-kb MRP8 cDNA. For hybridization, membranes were blocked for more than 4 hr, hybridized for 15 hr, rinsed in 2ϫ SSC/0.1% SDS at room temperature, and finally washed twice in 0.1ϫ SSC/0.1% Sodium Dodecyl Sulfate at 65ЊC.
PCR Rapid Scan Gene Expression Panel
A rapid scan gene expression panel, containing PCR-ready first-strand cDNA from 24 different tissues (Cat# HSCA-101; OriGene, Rockville, MD, USA) was used as a template for PCR with a primer pair (T352 and T354) that should give a 400-bp fragment. For expression analysis of MRP8 in normal breast and breast cancer, we have used a Human breast cancer rapid scan panel (Cat# TSCE-101; OriGene,), which contains PCR-ready first-strand cDNA from 12 normal and 12 breast cancer tissues. PCR composition and conditions used are according to the supplier's instructions.
RACE PCR Analysis for Identification of Full-Length cDNA
Rapid amplification of cDNA ends (RACE) was performed on Marathon Ready normal breast and testis cDNA (Clontech). Gene-specific primers T360 and T359 were used for the 5Ј and 3Ј RACE, respectively. The RACE PCR product was gel purified (QIAquick gel extraction, Qiagen, Santa Clara, CA, USA) and cloned into the pCR2.1 TOPO vector (Invitrogen, Carlsbad, CA, USA). Different clones were analyzed by restriction digestion using EcoRI restriction enzyme. The longest clones were sequenced using Perkin-Elmer's dRhodamine terminator sequencing kit (Perkin-Elmer Applied System, Warrington, UK).
In Vitro Translation
The in vitro translation of the 4.5-and 4.0-kb variants of MRP8 cDNA was examined in an in vitro transcription coupled translation system using T7 RNA polymerase and rabbit reticulocyte extract (TNT, Promega, Madison, WI, USA).
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S-Met (ICN, Costa Mesa, CA, USA) was incorporated in the reaction for visualization of translated products. The reaction mixture was heated at 37ЊC in the presence of 5 M of urea and then analyzed under reducing condition on a polyacrylamide gel (7.5% Tris/Glycine, Bio-Rad) together with a pre-stained marker (Bio-Rad, Richmond, CA). The gel was dried and subjected to autoradiography.
Results
EST Database Mining for the Identification of Breast-Specific EST Clusters
As part of our search for genes expressed in breast cancer, we identified a cluster of ESTs, referred to as Br001, which consists of six ESTs; three ESTs (AW372855, AW372856, AW372862) are from a breast cancer library, and three from a normal prostate (AI401832, AI676121, BF447217) library (Fig. 1) . By assembling the six ESTs, we obtained a 369-nucleotide sequence that contains a polyadenylation site (TATAAA). The cluster contains no ESTs from T352  TAC AGA TGT GGT GGA AAA  CGG TGG  T354  CTC CAT GAA GTC TCC ACA  TCT CCT  T357  GGA GAA CCA CAT GAT CAC  TGA ATC CCA TGT C  T359  CCT AGT ACT GAT CAC CTG  CGC ATC GCT  T360  AGC GAT GCG CAG GTG ATC  ACT AGG  T377  GTC ACC TGG ATG GTG TAA  AGG AAA CAA GAG  T389  AAG CGA CTC CGT AAG CTT  TGG ATC ATG AGC other tissues, which suggests that the Br001 transcript might only be expressed in breast and prostate tissues.
Specificity Analysis by Dot Blot and Rapid Scan RT-PCR Analysis
To examine the computerized EST database analysis experimentally, we performed a mRNA dot blot (human multiple tissue expression array, Cat# 7775-1, Clontech) analysis using a PCR-generated probe (3Ј probe; Fig. 5 ) from the consensus EST sequence of cluster Br001. As shown in Figure 2A , among the 76 samples of normal and fetal tissues, Br001 is detected strongly in human testis (F8), breast (F9), and weakly in liver (A9). A very weak signal is also detected in prostate (E8) and placenta (B8). To confirm the dot blot result, we conducted a PCR using the human rapid-scan multi-tissue cDNA panel (Origene) with primers T352 and T354. This rapid scan panel consists of cDNAs derived from 24 different tissues and the cDNAs are serially diluted over a 4-log range and arrayed into a multi-well PCR plate. As shown in Figure 2B , the expected 400-bp PCR product was evident in testis and less intense in liver. Because this multi-tissue cDNA panel does not have any sample from human breast, we added corresponding amount of human breast cDNA (Clontech) in 1 of the 96 wells and ran the PCR at the same condition. As shown in Figure 2B , lane 13, a 400-bp PCR product is detected in the breast lane and the intensity of the band is comparable with the band in the testis lane. This 400-bp product was also weakly detected in adult and fetal brain and liver as well as in placenta and prostate. The relative expression in prostate, placenta, brain, and liver is 10-100 times lower than in breast and testis (data not shown).
Analysis of the Genomic DNA to Identify Genes Around the Tissue-Specific EST Cluster
The EST cluster Br001 maps on chromosome 16q12.1 and the accession number for the corresponding genomic contig is AC007600. In the "Golden Path" human genome browser, there is only one mRNA (accession number AL11706) reported as full-length, which is in fact a fully sequenced cDNA clone from a library made from human testis. There is no other known gene reported in this region (Fig. 1) . We analyzed about 180 kb of genomic sequences around the cluster Br001 for genes predicted to encode membrane proteins using different gene prediction programs. As shown in Figure 1 , GenomeScan (9) predicted two large genes, both of which code for membrane proteins. One of the two genes includes the breast-specific cluster Br001. A BLAST search (10) with the deduced full amino acid sequence of the predicted gene against the GenBank nr database resulted in significant hits with ABC super family proteins (11), in particular with MRP5, which belongs to ABCC subfamily (12, 13) . Because Br001 is a new member of ABCC subfamily and currently there are seven identified members of MRPs, we named this gene MRP8. Amino acid sequence analysis suggests that MRP8 is a full transporter and has two conserved nucleotide binding domains and 12 putative transmembrane domains (12) . Further analysis of the amino acid sequence reveals that MRP8 has overall a 42% identity and 51% similarity with the MRP5 sequence. The other gene predicted by the GenomeScan program has homology with MRP groups of proteins and is located downstream of MRP8. We named this gene MRP9 (ABCC12) and the characterization of this gene will be reported elsewhere.
Expression of MRP8 in Normal Breast and Breast Cancer
To investigate whether MRP8 is expressed in different normal breast and breast cancer samples, an RT-PCR analysis was carried out using the human breast cancer rapid-scan panel from Origene. In this panel, cDNAs from 12 different normal breast and 12 different breast cancer tissues are arrayed into a multi-well PCR plate. As shown in Figure 2C , using the PCR primer T352 and T354, the expected 400-bp PCR product was weakly detected in 8 out of 12 normal breast samples tested. Importantly, in 10 of the 12 breast cancer samples this 400-bp band was 10-100 times stronger than in normal breast.
Northern Analysis of MRP8
To determine the size of the MRP8 transcript expressed in testis and breast tissue we used a multiple tissue northern blot (Clontech). As shown in Figure   3A , MRP8 is detected in breast (lane 1), testis (lane 3), and liver (lane 4), and these differ in size. There is one distinct transcript of about 4.5 kb in the breast lane, whereas the transcript size in testis and liver is about 4.1 kb. In the rapid scan RT-PCR analysis, brain tissue was positive for MRP8 expression. In the Northern blot analysis we are not able to detect any band in brain, probably because Northern analysis is much less sensitive than the RT-PCR. There is high expression of the MRP8 transcript in the breast cancer cell line HTB20 (lane 5) and the transcript size is 4.5 kb. which is similar to the size observed in normal breast. The expression profile of MRP8 in different tissues as determined by dot blot, Northern blot, and RT-PCR analysis is summarized in Table 2 .
Full-Length cDNA Cloning and Analysis of the cDNA
To isolate the full-length MRP8 cDNA, we performed a 5Ј and 3Ј RACE-PCR using normal breast cDNA (Marathon-Ready cDNA, Clontech) with the primers designed from the sequence predicted by the gene prediction program. The antisense primer T360 was used for 5Ј RACE and the sense primer T359 was used for 3Ј RACE reaction. Both primers contain the predicted sequence of exon five (exon 8 of the experimental clone, Fig. 4) . The RACE-PCR analysis at the 5' end gave a 1-kb band, and the 3' RACE gave a 3.5-kb band. After subcloning and sequencing of the PCR products, we obtained the complete sequence of MRP8 cDNA. Primers T377 and T357 were used to obtain a full-length MRP8 clone from human breast cDNA. The full-length cDNA is 4538 bp long and has a long ORF of 1382 amino acids starting at bp 146 and ending at 4202. The calculated molecular weight of the protein encoded by the ORF is about 150 kDa. As shown in Figure 5 , the full-length cDNA consists of 31 exons and is located in a genomic region of over 80.4 kb on chromosome 16q12.1. To determine if the exons and introns predicted by the GenomeScan program are correct, we compared the nucleotide sequences of the MRP8 cDNA clone with the predicted exons. Out of 31 exons determined experimentally, 26 were predicted by the GenomeScan program, of which 23 were exactly the same, but 3 had incorrect boundaries (donor/acceptor site). There are 5 exons (1, 2, 4, 8, and 14) in the experimental clones (Fig. 4) that are not predicted by the program.
Long MRP8 Transcript Is Specifically Expressed in Breast Tissue
Several attempts to clone a 4.5-kb MRP8 cDNA from liver and brain cDNA libraries failed, even though the MRP8 cDNA is detected by RT-PCR analysis ( Fig. 2A) . To determine if the MRP8 transcript is unique to the breast tissue at the 5Ј end, we performed Northern analysis using a radiolabeled DNA probe designed from the very 5Ј end (bp 1-480) of the MRP8 cDNA. In this analysis a multi-tissue Northern blot containing 2 g of mRNAs from eight essential human tissues including liver was used. For a breast sample, 2.5 g of mRNA from breast cancer cell line HTB20 was analyzed. As shown in Figure 3B and summarized in Table 2 , a 4.5-kb MRP8 transcript is detected in the HTB20 (lane 2), but not in liver (lane 1). These data indicate that the 4.5-kb transcript of the MRP8 is specifically expressed in the breast tissue. 
Probes: 3Ј probe can hybridize to both 4.5-kb and 4.1-kb variants of MRP8, whereas 5Ј probe is specific for 4.5-kb transcript. Signal intensity: ϩϩϩϩ, high; ϩϩϩ, medium; ϩϩ, low; ϩ, very low; Ϫ, undetectable; ND, not determined. The predicted open reading frame for breast variant starts at exon 3 and ends at exon 31, whereas the open reading frame for testis variant starts at exon 9 and ends at exon 31. Both transcripts use the same reading frame. The region of cDNA sequences used for Northern hybridization are indicated as 3Ј probe and breast-specific probe.
The primers T352 and T354 are used for rapid scan RTPCR analysis, and T359 and T360 are used for 3Ј and 5ЈRACE analysis, respectively. 
Analysis of the MRP8 Transcript Expressed in Testis
Northern blot analysis of MRP8 detects a 4.1-kb band in the testis lane, which is smaller than the band in the breast lane (Fig. 3) . The difference in transcript size in two different tissues could be the result of either alternate splicing or a different transcription start site. To analyze the testis-specific transcript, we isolated the MRP8 cDNA by two different approaches. First, we performed a RACE-PCR analysis using testis cDNA (Marathon-Ready cDNA, Clontech) with the primers designed from the sequence predicted by the gene prediction program as we have done earlier with breast cDNA. Second, we utilized a "High-throughput Longestclone cDNA library screening" service from Origene to obtain an MRP8 clone from the testis cDNA library. From both sources, we isolated an MRP8 clone that is about 4.1 kb in size and matches with the transcript size we observed in the Northern blot analysis. Complete nucleotide sequence analysis of the 4.1-kb cDNA indicates that it has an ORF of 1064 amino acids starting at bp 457 and ending at bp 3648. As shown in Figures 4A and 4B , the cDNA consists of 26 exons, and exons 2-26 match exactly with the cDNA from the human breast. The first exon for the testis variant starts from a region of intron 6 of the breast variant (Fig. 4A) . As a result, the translated product for the testis variant lacks the first 319 amino acids that are present in the MRP8 clone from breast. This finding indicates that the smaller transcript size in testis is probably due to an alternate transcriptional start site and not due to an alternate splicing event.
In Vitro Transcription and Translation of the cDNA
The MRP8 cDNA isolated from breast and testis has a predicted open reading frame of 1382 amino acids and 1063 amino acids, respectively. To determine the actual size of the protein encoded by the two different MRP8 transcripts isolated from breast and testis, in vitro transcription and translation was performed using rabbit reticulocyte lysate system. SDS-PAGE analysis and fluorography of the translated product showed (Fig. 5) that the 4.5-kb cDNA from breast encodes a protein product of about 150 kDa in size (lane 5), whereas the protein product for the 4.1-kb transcript from testis is about 120 kDa in size (lane 3). The sizes of the protein products from the in vitro transcription and translation experiment agree with the predicted open reading frames of the cDNAs.
Discussion
We used a functional genomics approach to identify and clone a new member of the ABC superfamily of proteins and demonstrated by several experimental techniques that this newly identified gene is highly expressed in breast cancer, moderately expressed in breast and testis, and expressed at a very low levels in liver and brain. The deduced amino acid sequence of this gene has high homology with MRP5 and we named the gene MRP8 (ABCC11).
MRP8 Is a Member of ABC Superfamily and Belongs to ABCC Subfamily
The multidrug resistance/ATP-binding cassette (MDR/ABC) superfamily of membrane transporters is involved in energy-dependent transport of a variety of substrates across the membrane. In humans there are seven subfamilies (ABC-A to -F) based primarily on the sequence similarities. The sequence of MRP8 is closely related to MRP5 (Fig. 6) , which belongs to the ABCC subfamily. It has an overall 42% identity and 51% similarity with the MRP5 sequence. MRP8 has 12 distinct membranespanning regions and two conserved nucleotide binding domains (NBD), indicating that MRP8 is a full transporter. Although there are seven reported members of the MRP family, very little is known about the physiologic functions of these proteins. MRP1 and MRP2 are the most extensively studied members of this group. The tissue distribution of MRPs is different: MRP1 and MRP5 are ubiquitously expressed whereas MRP2 and MRP6 are predominantly expressed in liver and kidney (12, 13) . Our studies indicate that the MRP8 has restricted tissue distribution and is predominantly expressed in testis and breast. In addition, a shorter variant of MRP8 is expressed in testis and liver. The testis variant of MRP8 was characterized and found to lack the first four membrane spanning regions. The physiological functions of MRP8 and its variant are yet to be determined. The region of the chromosome 16q12, where both MRP8 and MRP9 are located, has been implicated for the potential candidate gene(s) for paroxysmal kinesigenic choreoathetosis (PKC; 14) and infantile convulsions with paroxysmal choreoathetosis (ICCA; 15). 
